Zeta Global Holdings Corp. (NASDAQ:ZETA – Get Free Report) has received a consensus recommendation of “Buy” from the five analysts that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $15.00.
ZETA has been the topic of a number of recent analyst reports. Barclays increased their price objective on Zeta Global from $14.00 to $15.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 28th. William Blair restated an “outperform” rating on shares of Zeta Global in a research report on Wednesday, February 28th. Morgan Stanley upgraded Zeta Global from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $12.00 to $17.00 in a research report on Thursday, April 4th. Needham & Company LLC restated a “buy” rating and set a $13.00 price target on shares of Zeta Global in a research report on Wednesday, February 28th. Finally, TheStreet upgraded Zeta Global from a “d+” rating to a “c-” rating in a research report on Tuesday, January 30th.
Zeta Global Trading Down 2.2 %
Zeta Global (NASDAQ:ZETA – Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.36). Zeta Global had a negative return on equity of 123.59% and a negative net margin of 25.73%. The business had revenue of $210.00 million during the quarter, compared to analysts’ expectations of $207.53 million. During the same quarter last year, the business posted ($0.36) EPS. The company’s quarterly revenue was up 19.9% on a year-over-year basis. On average, equities research analysts anticipate that Zeta Global will post -0.45 EPS for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the stock. Insight Wealth Strategies LLC bought a new position in shares of Zeta Global during the fourth quarter valued at about $922,000. Legato Capital Management LLC bought a new position in shares of Zeta Global during the fourth quarter valued at about $929,000. Vanguard Group Inc. grew its stake in shares of Zeta Global by 6.6% in the third quarter. Vanguard Group Inc. now owns 15,915,616 shares of the company’s stock worth $132,895,000 after purchasing an additional 991,678 shares during the last quarter. Blue Trust Inc. grew its stake in shares of Zeta Global by 22.8% in the fourth quarter. Blue Trust Inc. now owns 10,960 shares of the company’s stock worth $92,000 after purchasing an additional 2,037 shares during the last quarter. Finally, First Eagle Investment Management LLC grew its stake in shares of Zeta Global by 97.2% in the third quarter. First Eagle Investment Management LLC now owns 663,600 shares of the company’s stock worth $5,541,000 after purchasing an additional 327,100 shares during the last quarter. 75.82% of the stock is owned by institutional investors.
About Zeta Global
Zeta Global Holdings Corp. operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally. The company's Zeta Marketing Platform analyzes billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry's opted-in data set for omnichannel marketing; and Consumer Data platform ingests, analyzes, and distills disparate data points to generate a single view of a consumer, encompassing identity, profile characteristics, behaviors, and purchase intent.
Featured Articles
- Five stocks we like better than Zeta Global
- How to Use the MarketBeat Dividend Calculator
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is a Dividend King?Ā
- Hilton Demonstrates Asset Light is Right for Investors
- What is MarketRankā¢? How to Use it
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Zeta Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeta Global and related companies with MarketBeat.com's FREE daily email newsletter.